Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FWAET
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) for XOLAIR 150 MG/ML Syringe. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, is being performed at the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace leveraging its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026. This umbrella contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting military health facilities worldwide. XOLAIR (omalizumab), a biologic medication used in respiratory and allergic conditions, represents part of the contractor's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables that support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FWAET?
SPE2DB25FWAET was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FWAET worth?
The government has obligated $1,547 on SPE2DB25FWAET.
Is contract SPE2DB25FWAET an order under another contract?
Yes. SPE2DB25FWAET is a delivery order under SPE2DB25D9322, an indefinite delivery contract.
Was contract SPE2DB25FWAET competed?
The extent of competition for SPE2DB25FWAET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award